TABLE OF CONTENTS · The Pithampur-Dhar-Mhow Investment Region is one of the proposed 24 nodes...

TABLE OF CONTENTS

2

Chapters Particulars Page No

1. Introduction & Background

Vikram Udyogpuri Industrial Township

SPV-Board Of Directors

National Industrial Corridor Development & Implementation Trust

Delhi Mumbai Industrial Corridor Development Corporation

3

4

5

5

2. Invitation 6

3. India : Pharmaceutical Sector

Highlights

Pharma Cluster-States of India

Market Size

Key Government Initiatives

Manufacturing Cost Index

GOI Measures Supporting Growth of Pharma Industry

Incentives-GOI

7

7

8

9

10

11-12

13-14

4.

Madhya Pradesh : Pharmaceutical Sector

Pharma Scenario-State of MP

Incentives-GoMP

Industrial Policy 2014 (amended in 2017)-GoMP

15-17

18

19-22

5. Advantage Vikram Udyogpuri

Location Map of Ujjain (MP)

Land Use Plan and Sale Rates

Utilities Offered

Land Allotment Process

23

24

25-27

28-32

33-34

6. Contact Details 35

Vikram Udyogpuri near Ujjain

The Pithampur-Dhar-Mhow Investment Region is one of the

proposed 24 nodes under Delhi Mumbai Industrial Corridor

(DMIC) Project, which is conceived as a model industrial

corridor of international standards to expand manufacturing

and service base of its influence area. The Pithampur-

Dhar-Mhow Investment Region is located in Madhya

Pradesh (MP) and covers an area of 372 square kilometer.

It is one of the seven nodes identified for development in

the first phase of the DMIC Project.

For development of this region, The Government of India

through Delhi Mumbai Industrial Corridor (DMIC Trust) and

the Government of Madhya Pradesh has formed a SPV

DMIC Vikram Udyogpuri Limited.

Government of Madhya Pradesh will be majority

shareholder in the SPV and will always hold 50.45%

(MPTRIFAC 25.73% and MPAKVN 24.72%) equity while

Government of India(through DMICDC Trust) will hold the

remaining 49.55% shares in the SPV. DMICDC Trust has

contributed equal the cash equity of Rs. 55.93 Crore during

the first five years of the operation of the SPV. Government

of Madhya Pradesh will contribute the land for the

implementation of the project as equity.

INTRODUCTION AND BACKGROUND

3

DMIC VIKRAM UDYOGPURI LIMITED - BOARD OF DIRECTORS

4

Shri Mohammed Suleman , IAS

Chairman/Director

Principal Secretary, Department of Industry Policy & Investment Promotion, Govt. of MP,

Bhopal

Shri Basant Kurre, IAS

Managing Director

Additional Collector, Ujjain. (MP)

Shri Davinder Pal Ahuja, IAS

Director

Managing Director, Madhya Pradesh Trade & Investment Facilitation Corporation Limited,

Bhopal (MP)

Shri Alkesh Kumar Sharma, IAS

Director

CEO & MD, DMICDC, New Delhi.

Shri Abhishek Chaudhary

Director

Company Secretary and VP-Corporate Affairs & Human Resources, DMICDC, New Delhi

Shri Pradeep Kumar Agarwal

Director

Chief Financial Officer, DMICDC, New Delhi

DMIC VIKRAM UDYOGPURI LIMITED - BOARD OF DIRECTORS

5

National Industrial Corridor Development & Implementation Trust (NICDIT)

NICDIT is an apex body under the administrative control of DIPP for coordinated and unified

development of all the industrial corridors in the country. It will channelize the Government of India

(GoI) funds as well as institutional funds while ensuring that the various corridors are properly

planned and implemented keeping in view the broad national perspectives regarding industrial and

city development and will appraise and approve projects and support project development

activities. It will coordinate all central efforts for the development of Industrial Corridor projects and

will monitor their implementation.

Delhi Mumbai Industrial Corridor Development Corporation (DMICDC)

Delhi - Mumbai Industrial Corridor (DMIC) is India’s most ambitious infrastructure programme

aiming to develop new industrial cities as “Smart Cities” and converging next generation

technologies across infrastructure sectors. The objective is to expand India’s Manufacturing &

Services base and develop DMIC as a “Global Manufacturing and Trading Hub”. The programme

will provide a major impetus to planned urbanization in India with manufacturing as the key driver.

In addition to new Industrial Cities, the programme envisages development of infrastructure

linkages like power plants, assured water supply, high capacity transportation and logistics facilities

as well as softer interventions like skill development programme for employment of the local

populace. In the first phase eight new industrial cities are being developed. The programme has

been conceptualized in partnership and collaboration with the Government of Japan.

INVITATION

DMIC Vikram Udyogpuri Limited hereby Invites all Pharmaceutical Companies

to come and Invest in the mentioned Investment Zone and be part of India’s and

State of Madhya Pradesh Success Story.

Details of all facilities and Incentives offered are hereby mentioned in the

following chapters.

6

INDIA: PHARMACEUTICAL SECTOR

• Highlights The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value, and it accounts for 20 per cent in the volume terms and 1.4 per cent in value terms of the Global Pharmaceutical Industry as per a report by Equity Master. India is the largest provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume.

• Pharma Clusters – State of Madhya Pradesh

7


Market Size

• Indian pharmaceutical sector is estimated to account for 3.1 – 3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms.

• India’s pharmaceutical exports stood at US$ 16.8 billion in 2016-17 and are expected to grow by 30 per cent over the next three years to reach US$ 20 billion by 2020, according to the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL).

• Indian companies received 304 Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.

• India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture, bio-industry and bioinformatics is expected grow at an average growth rate of around 30 per cent a year and reach US$ 100 billion by 2025. Biopharma, comprising vaccines, therapeutics and diagnostics, is the largest sub-sector contributing nearly 62 per cent of the total revenues at Rs 12,600 crore (US$ 1.89 billion).

8


Key Government Initiatives

• The Government of India is planning to set up an electronic platform to regulate online pharmacies under a new policy.

• The Government of India unveiled 'Pharma Vision 2020' aimed at making India a global leader in end-to-end drug manufacture. Approval time for new facilities has been reduced to boost investments.

• The Government introduced mechanisms such as the Drug Price Control Order and the National Pharmaceutical Pricing Authority to deal with the issue of affordability and availability of medicines.

• The Union Cabinet has given its nod for the amendment of the existing Foreign Direct Investment (FDI) policy in the pharmaceutical sector in order to allow FDI up to 100 per cent under the automatic route for manufacturing of medical devices subject to certain conditions.

9


Manufacturing Cost Index

• India’s cost of production is nearly 33 per cent lower than that of the US.

• Labour costs are 50–55 per cent cheaper than in Western countries. The cost of setting up

a production plant in India is 40 per cent lower than in Western countries.

• Cost-efficiency continues to create opportunities for Indian companies in emerging

markets & Africa.

• India has a skilled workforce as well as high managerial & technical competence in

comparison to its peers in Asia.

• India has the 2nd largest number of USFDA-approved manufacturing plants outside the US.

• India has 2,633 FDA-approved drug products. India has over 546 USFDA-approved

company sites, the highest number outside the US.

10

Measures Supporting Growth of Pharmaceutical Industry Government of India

11

Reduction in Approval

Time for new Facilities

Steps Taken to reduce approval time for new

Facilities

NOC for export license issued in two weeks

compared to 12 weeks earlier

Collaborations MOUs with USFDA, WHO, Health Canada etc to

boost growth in India Pharma Sector benefitting from

their Expertise

Support for Technology

and FDIs

Union Cabinet has given nod to allow FDI upto 100%

under the automatic route for manufacturing of

medical devices

Government to create a digital platform to regulate

and track the sale of quality drugs, and it can be used

any-where in the world

Measures Supporting Growth of Pharmaceutical Industry Government of India

12

Pharma Vision 2020 Government aims to make India a major hub for

end-to-end drug discovery

Plan to set up mega bulk drug parks in order to

reduce industry’s dependency on raw material

imports

OTC Drugs A new category of over the counter (OTC) drugs has

been given in-principal. The category includes muscle

relaxants, decongestants, anti-inflammatory drugs,

anticids, external preparation for skin and hormonal

contraceptives

Online Pharmacies Plan to set up an electronic platform to regulate

online pharmacies under a new policy

India Infrastructure Under the Union Budget 2016-17, Government has

announced to set up 1.5 lakh Health Care Centres

and open two new AIIMS in Jharkhand and Gujarat

INDIA: PHARMACEUTICAL SECTOR Incentives - Government of India

Export Linked

13

Export Oriented Unit

Scheme

Exemption/Refund of various indirect taxes such as customs duty,

excise duty on the procurement of capital goods and inputs (as the

case be) for permitted operations

Export promotion

capital goods

Allows duty-free procurement of capital goods by exporters, subject to

the fulfillment of export obligation and other specified conditions

Duty Free Import

Authorization Scheme

Permit the import of inputs without customs duty, subject to the

fulfillment of value-added norms and export obligation

Served from India

Scheme

Available to specified service providers having service exports of

Rupee 1 million or more-for import/procurement of spares, office

equipment, furniture and consumables

Post export benefit allowed by way of duty credit scrip equivalent to

10% of the net foreign exchange earned in the current financial year

Duty Drawback Post export benefit to allows rebate of taxes and duty paid on inputs

and input services used in the manufacture of exported goods at

prescribed rates

Focus Product

Scheme

Post export benefit allowed by way of duty credit scrip equivalent to a

specified percentage of the FOB value of exports of specified products

to any country/ all products to notified countries

INDIA: PHARMACEUTICAL SECTOR Activity based

14

Weighted Deduction

for R&D Facilities

In-house R&D facility eligible for deduction @ 200% under

the Act

Employment of New

Workmen

Deduction equivalent to 30% of additional wages/ salary (over

and above expenditure on wages/ salary) available for three

years in respect of new workmen employed

MADHYA PRADESH : PHARMACEUTICAL SECTOR Madhya Pradesh – An attractive destination for Pharma Industry How big is Madhya Pradesh Pharmaceutical Industry?

• State of Madhya Pradesh have basic infrastructure, which attracted multinational pharmaceutical companies to setup pharmaceutical business in Madhya Pradesh.

• The pharmaceutical sector is spread all over M P. List of major pharmaceuticals companies at the following areas are as given below :-

Bhopal :- Bhopal Chemicals, Hind Pharma, H.V. Medico Industries, Biotech (India) Tech. PLtd.

Bhind :- High Light Drugs & Pharmaceuticals Ltd, Kashtharan Aushdhalaya.

Dewas :- Alchemist Remedies Pvt. Ltd., Sun Pharma, Novartis,

Dhar :- Emerson Labs Ltd, Harsh Vardhan Laboratories Pvt. Ltd, Indo Borex & Chemicals Ltd.

Gwalior :- Asian Remedices, Biopharma Pvt.Ltd, Crimson Pharmaceuticals Industries.

Indore :- Cipco Pharmaceuticals, Bio Medica Laboratories, Adman Formulations Pvt. Ltd.

Jabalpur :- Deogratias Parenteral, Guapha Pharmaceuticals, Haylide Chemical.

Mandideep :- Lupin Labs, Anjani Pharmaceuticals, Malwa Drug House.

Morena :- Bio Synth Pharmaceuticals Pvt. Ltd.

Pithampur :- Cipla Ltd, IPCA Laboratories Ltd, Unichem Laboratories Ltd, Glenmark Ltd.

Raisen :- Albert David Ltd, Aristo Pharmaceuticals Ltd, Lifespan Biotech Pvt. Ltd.

Sagar :- Biomax Remedies, Bro Shell Pharma, Kothari Laboratories.

Ujjain :- Askon Healthcare, Danish Laboratories, Herb Edge Healthcare Pvt. Ltd.

15

MADHYA PRADESH : PHARMACEUTICAL SECTOR

Potential of Pharmaceutical industry

• The Pharmaceutical industry in Madhya Pradesh has an annual turnover of about USD

1.5 billion

• More than 350 pharmaceutical units located across Madhya Pradesh, out of which 160

are formulation manufacturers.

• Provides direct and indirect employment to more than 45,000 people

• Cipla, Novartis, Sun Pharma, IPCA, Lupin Labs are the major anchor units of the sector

in state.

Market Size of Madhya Pradesh Pharma Industry

There are four major types of pharmaceutical companies are operating in Madhya

Pradesh namely Active Pharmaceutical Ingredients (APIs), Contract Research and

Manufacturing Services (CRAMS), Formulations and Bio- similar with APIs.

16


Increase in demand for pharma students

• Number of colleges running pharmacy courses have been increasing day by day.

• Intake of students in pharmacy colleges has also observed a substantial increase per

year.

Indore: A Pharmaceutical hub of the state

• Indore is one of the biggest manufacturers of pharmaceuticals like drug formulations,

tableting, capsuling etc.

• Indore have one of country’s largest pharmaceutical trade house, “Dawa Bazar”

• Indore’s Dawa Bazar is one of Asia’s biggest pharmaceutical trade houses, where apart

from wholesale and retail outlets of small manufacturers of the cluster, multinational

and other big companies have marketing offices.

17

MADHYA PRADESH : PHARMACEUTICAL SECTOR Incentives of Government of Madhya Pradesh

• 50% of the expenditure incurred on technical services for obtaining certificate of Good Manufacturing Practices from the Madhya Pradesh Food and Drugs Administration would be reimbursed upto a maximum limit of Rs. One lakh.

• Special arrangements will be made for speedy disposal of departmental formalities by the licensing authority and other departments for manufacturers of drugs & herbal products.

• Pharmaceutical Industries would be encouraged to participate in international trade fairs.

• With a view to create integrated and excellent infrastructure in the areas with good prospects for development of Herbal and Ayurvedic products based industries, herbal parks and demonstration centers would be developed.

• Arrangements under the MOU signed between MP Laghu Vanopaj Sangh and Madhya Pradesh Trade and Investment Facilitation Corporation Ltd. for promoting export of medicinal plants and herbs would be continued.

• Generally the scope of establishing Herbal & Ayurvedic industries exists in advanced districts like Bhopal, Indore etc. Therefore, Herbal & Ayurvedic industries setup in all such advanced districts will be provided State Investment Subsidy, Industrial Investment Promotion Assistance like Backward ‘A’ category districts. 18

MADHYA PRADESH : PHARMACEUTICAL SECTOR Industrial Promotion Policy, 2014 ( Amended as of October, 2017)

Category of Industrial Unit as per the Policy

• Classification of Industrial Units

*For the purpose of incentives and their applicability, plant &machinery shall mean investment made in plant &machinery, buildings & sheds, but shall not include land & dwelling units.

19

S.No. Type of Industrial Unit Description

1 Micro scale industrial unit A manufacturing enterprise having an investment less than INR 25 lakh in plant & machinery

2 Smallscale industrial unit A manufacturing enterprise having an investment between

INR 25 lakh and INR 5 crore in plant & machinery

3 Medium scale industrial unit

A manufacturing enterprise having an Investment

between INR 5 crore and INR10 crore in plant &

machinery

4 Large scale industrial unit

A manufacturing enterprise having an Investment more

than INR 10 crore in plant & machinery

5 Mega scale industrial unit

An unit having an investment more than:

§ INR 100 crore in plant & machinery

§ INR 25 crore in plant & machinery in sectors including

Food Processing, Bio-technology, Herbal & Minor forest

produce, Tourism & IT

MADHYA PRADESH : PHARMACEUTICAL SECTOR Capital subsidy : Subsidy on plant & machinery only to eligible units will be given as below:-

Interest Subsidy : Eligible units will get interest subsidy on term loan as given below:-

Entry tax exemption : Exemption from entry tax shall be as follows:-

20

S.

No.

Type of unit Percentage of

subsidy

Maximum amount of subsidy

(INR lakhs)

1 Micro & Small

scale industrial unit

15 Subject to a ceiling of INR 15 lakh

Type of Units Interest subsidy

Micro scale industrial unit 5% with annual ceiling of INR 3 lakh for 7 years

Small scale industrial unit 5% with annual ceiling of INR 4 lakh for 7 years

Medium scale industrial unit 5% with annual ceiling of INR 5 lakh for 7 years

S. No. Type of unit Entry tax exemption

1 Micro, Small,

Medium, Large

& Mega scale

industrial unit

§ Five years for an investment made upto INR 500

crore in plant & machinery

§ Seven years for an investment more than INR 500

crore made in plant & machinery

MADHYA PRADESH : PHARMACEUTICAL SECTOR *VAT & CST Assistance: Eligible enterprises (except textile units) will be given

reimbursement after adjusting the input tax rebate on the amount of value added tax (VAT) and central sales tax (CST) (excluding the amount of value added tax on purchase of raw materials) deposited by them to the extent shown below:

** Priority block: Blocks having no large/mega scale industrial unit as on policy notification

date. The amount of assistance provided to the units shall not exceed the total investment made in plant and machinery.

21

S. No. Type of unit Eligibility under “**Priority

block”

Eligibility for all

other remaining

districts

1 Micro and small

manufacturing enterprises

having fixed capital investment

of at least INR 1 crore and

Medium scale industrial unit

50% for a period of 7 years 50% for a period of

5 years

2 Large & Mega scale industrial

unit

75% for a period of 10 years 75% for a period of

7 years


Electricity duty exemption: All eligible units having ‘High Tension (HT)’

connection by any DISCOM in the state by 3rdMarch 2019 shall be exempted from

electricity duty as given below on terms and conditions brought over vide

notification no.F-3-23-2013-XIII published in Gazette of Madhya Pradesh

(extraordinary) on 4th March 2014.

22

S. No. Type of unit Period of exemption

1 Micro, Small, Medium, Large

& Mega scale industrial unit

§ For 33KV connection :Up to a period of 5 years

§ For 132KV connection: Up to a period of 7 years

§ For 220KV connection: Up to a period of 10 years

ADVANTAGE VIKRAM UDYOGPURI

The Government of M.P and VUL has adopted the mechanism of town planning

schemes (TP) to ensure delivery of serviced land that can benefit the local population

and the private sector. The TP Schemes are being implemented under the M.P. Town

Planning and Urban Development Act, 1976. Broadly, the TP mechanism is means of

land pooling for provision of infrastructure. Under TP schemes, 23.3% of an individual’s

land holding is aggregated for physical and social infrastructure. The 7.66% land

aggregated for infrastructure issued for roads, physical infrastructure, social

infrastructure, and other facilities and amenities. The land which will be used for

common infrastructure is known as 'public purpose' land; and detailed land use Saleable

Plan, is given in table at page no. 25.

23

Location map of Ujjain

24

Ujjain


LAND USE SALEABLE PLAN

25

TYPE OF LAND USE Proposed Area Hac Saleable area Hac

Industrial (Manufacturing) 186.47 185.26

Public and Semi-Public (PSP) 71.04 56.67

Recreational 66.60

Residential 71.04 69.82

Commercial 13.32 14.21

Transportation and

Communication 35.52

Total Area in Hac 443.97

Total Area Available for Allocation 325.96

ADVANTAGE VIKRAM UDYOGPURI Details of Land Availability along with relevant size (in Acres) and their Land Use

• Details of Land for Industrial Purpose

Rates of Industrial Plots is Rs. 184 per sq.ft 26

S.N. A-N Code Product Wise Area (Acre) Land use

1 M2-L Industry (Large Scale) 56 Industrial


3 M2-M Industry (Medium Scale) 30 Industrial




7 M2-S Industry (Small Scale) 8 Industrial

8 M-3 Logistic Facillity 18 Industrial

9 M2-S Industry (Small Scale) 48 Industrial



12 M1-ES Engineering Services 20 Industrial

13 M1-IT IT/ITES 20 Industrial

Total 448.00


• Details of Land for Public and Semi-Public (PSP)

Rates of Public and Semi-Public (PSP) is Rs. 198 per sq.ft

27

S.N. A-N Code Product Wise Area (Acre) Land use

1 PS-4 Health Centre - 1 1 Public and Semi-Public (PSP)

2 PS-4 Health Centre - 2 1.5 Public and Semi-Public (PSP)

3 PS4-M Medical Hub 40 Public and semi-Public (PSP)

4 PS-4 Health Centre - 3 2 Public and Semi-Public (PSP)

Total 44.5


DMIC Smart Cities are better poised to establish Pharma Units as compared to upcoming bio-pharma industrial parks in other states due to: • Availability of World Class Infrastructure.

• Flexibility in availability of Land.

• Provision of CFCs, PSPs & Housing Facility in the same premises of VUL.

• Nearness to BG Station will reduce transportation Cost.

Utilities (Water)

11 MLD treated water is envisaged by VUL for un-interrupted water distribution

system in Phase I at Vikram Udyogpuri, Ujjain through Narmada Shipra Link

Project of NVDA.

Utilities (Special Treatment Facilities)

The 11 MLD water treatment plant, under construction, is as per the norms set in

the “Centre Public Health and Environmental Organization” by Ministry of Urban

Development, New Delhi.

3 No. of Sewage Treatment Plant (STP) on plot No. 24 ,28 and 74 based on

modern technology MBBR, SBR with tertiary treatment as per the norms set in the

“Centre Public Health and Environmental Organization” by Ministry of Urban

Development, New Delhi, are under construction at VUL , Ujjain.

28


Utilities (Cold Storages/Supply Depots/bulk containerization for Pharma

Companies)

Sufficient Space is available with VUL and all the facilities can be developed at the

industrial site of VUL.

Utilities (Logistics and Supply Chain Network)

18 acre area is reserved for Logistics facilities in Industrial Area Plot No. 25 (M3) are

available as per approved Master Plan.

Internal Roads under construction are well designed 4 Lane roads with 4 Lane

approaches to adjacent Highways.

Utilities (Electricity)

220 KV Electric Sub-station is proposed for the VUL for power supply. At initial Level

33/11 KV Sub-station with dedicated MPPKVVCL Feeders shall provide Power to

VUL through double circuit Lines.

29


Research and Development Activities

Chokse Lab & other NABL Accredited Labs are operational at Indore from where all

the Pharma units of SEZ – Indore & Pithampur DTA (Like Lupin, Cipla, IPCA,

Unichem Lab, Nicholas Piramal etc.) are getting the Testing facilities. VUL is also

planning for various CFCs in the Industrial Area.

Arrangements to maintain Green and Clean Environment

Proposed Rain Water Harvesting System, Sewerage System & Recycling System,

Solid Waste Management System. 15.45 % is approx 170 acres of Industrial Area

land is allotted for City green and open space. Hazardous Waste disposal facility is

also available at Pithampur which is about 90 Kms from VUL.

Facilities for Workers and Families-Social Infrastructure

City Green, Recreational Clubs, Open Space etc., Engineering Hub, Medical Hub,

Industrial Training Institutes Hub, 'Utility' Buildings etc. approx 350 acre of I/A land is

proposed for PSP / Social Infrastructure.

30

ADVANTAGE VIKRAM UDYOGPURI Chain of Connectivity

31

Railways

Highways

Airports

Dry Ports

Connectivity with DMIDC Corridor –Nagda70 KM.

Nearest Railway Station - Karcha 1.5 Km on Indore – Ujjain

Broad Gauge Railway Line.

Nearest Railway Junction- Ujjain & Dewas - 20 Km.

Nearest National Highway –18 Km (Mumbai – Agra-Delhi Road-

NH – 3)

Nearest State Highways – SH 18 is 2.50 Kms with 4 Lane

connectivity under construction as Access Road 1.

Nearest Airport - Indore 55 Km

Nearest Dry Port - ICD Pithampur – 85 Kms.

- ICD Dhannad - 80 Kms.


Obligations/ Responsibilities of Pharma Companies:

The effluents of the Pharma Companies shall be treated by themselves.,

The Solid Waste of the Pharma Companies shall be treated by themselves.,

The Storage of the Pharma Products shall be constructed by the Pharma

Companies by themselves.,

32

LAND ALLOTMENT PROCESS

Procedure of Allotment of Site / Land / Development Rights

Allotment process shall be in accordance with the following:-

1. Development Plan (DP), Town Planning Scheme, and General Development

Control Regulations (GDCR) as prepared by DMICVUL.

2. Pricing Policy for various land uses as prescribed by DMICVUL.

3. The Land Disposal will be done as per First Come First Serve Basis (FCFS).

33

LAND ALLOTMENT PROCESS Process of Allotment through FCFS

• Allotment of Land will be done through Online Application on website : www.invest.mp.gov.in

• From the submission of application, presentation of applicant is scheduled within 5 days

before Committee based on which decision is taken for allotment of Land and other

Infrastructure.

• On the basis of approval from Committee, the selection of Plot / Site by Applicant is done.

• The DMICVUL shall provide Provisional Allotment letter against down payment of 25% of total

cost. The down payment must be completed within 10 days from date of approval by

Land Management Committee.

• The balance payment (75%) must be deposited within 30 days from date of Provisional

Allotment Letter,. The Allotment letter will be provided by DMICVUL to allottee immediately

on receipt of balance payment.

• The Agreement with the allottee shall be executed within 3 working days after the

balance payment is received and allotment letter is provided to the allottee.

• Possession letter and handing over of possession of plot will be given within 15 days of

balance payment for plot / site.

• The construction must commence within 6 months from the date of allotment letter and

production must commence within 3 years of date of allotment.

34

CONTACT DETAILS

To know more and get in touch with us:

MANAGING DIRECTOR

DMIC VIKRAM UDYOGPURI LIMITED

Ground Floor, Nanakheda Bus Stand Parisar

Indore Road, Ujjain-456010 (MP)

Phone: 0734-2524763/2524980/2524981

Fax: 0734-2524982

E-mail: [email protected]

Website: www.invest.mp.gov.in

35

mailto:[email protected]



TABLE OF CONTENTS · The Pithampur-Dhar-Mhow Investment Region is one of the proposed 24 nodes...

Documents

Transcript of TABLE OF CONTENTS · The Pithampur-Dhar-Mhow Investment Region is one of the proposed 24 nodes...